Companies

Becton Dickinson & Company

NYSE: BDX
$198.33
▲ $3.17 (+1.62%) today
Markets closed · 6:06pm ET

24/7 Wall St. View

BDX at a Glance

Price
24/7 target
$218.20
Street target
$195.57
Earnings
Next report
Nov 5, 2026

NYSE: BDX

About Becton Dickinson

Becton, Dickinson and Company (BD) is one of the world's largest pure-play medical technology companies, focused on advancing health through innovation across four business segments: Medical Essentials, Connected Care, BioPharma Systems, and Interventional. Following the February 2026 spin-off of its Biosciences and Diagnostic Solutions business (combined with Waters Corporation), BD operates as 'New BD' with a streamlined focus on MedTech. The company develops and manufactures medical devices, instrument systems, and reagents used by healthcare institutions, clinical laboratories, pharmaceutical companies, and the general public. Key product areas include medication delivery solutions, specimen management, medication management systems, advanced patient monitoring, pharmaceutical delivery systems (including injection pens for GLP-1 therapies), peripheral intervention devices, urology and critical care products, and surgical instruments. BD employs more than 60,000 people globally and delivers billions of products annually that impact healthcare worldwide. Updated

Latest Activity

BDXBecton Dickinson
New 52-week high$193.76+1.5% vs prior high · 2026-08-21

Becton Dickinson closed at $193.76, a fresh 52-week high and 1.51% above the prior peak set on August 21. The $52.8 billion medtech name spent most of the spring in the $140s.

BDX Coverage

2:38pm ET
Investing

3 Undervalued Dividend Kings to Buy on the Dip Right Now

Dividend Kings are stocks that’ve had their dividend payouts raised for 50 consecutive years or more, such as Target (NYSE:TGT | TGT Price Prediction), Becton Dickinson (NYSE:BDX), and Hormel Foods (NYSE:HRL). That…

Omor Ibne Ehsan

Frequently Asked Questions

What does Becton Dickinson do?

Becton, Dickinson and Company (BD) is one of the world's largest pure-play medical technology companies, focused on advancing health through innovation across four business segments: Medical Essentials, Connected Care, BioPharma Systems, and Interventional.

What is the BDX stock price target?

24/7 Wall St.'s 12-month price target for BDX is $218.20, rated Buy. The Wall Street consensus target is $195.57. BDX price prediction →